Skip to content

MindspaceOne Effects of a smartphone-based combination of hypnotherapy and aromatherapy to imprint the ability to relax in a targeted manner

MindspaceOne Effects of a smartphone-based combination of hypnotherapy and aromatherapy to imprint the ability to relax in a targeted manner

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034509
Enrollment
500
Registered
2024-06-24
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy participants will be analysed. Stress reduction

Interventions

Group 1: Group I: Hypnosis and aroma participants in this group receive a 15-minute smartphone-based hypnotherapy intervention three times a week combined with the independent application of a specifi

Sponsors

Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie Charité Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Residence in Germany, use of your own smartphone or PC to use the relaxation sessions

Exclusion criteria

Exclusion criteria: Previous or concomitant mental illnesses now or in the last 3 years, active psychotherapy, active hypnotherapy

Design outcomes

Primary

MeasureTime frame
Primary endpoint: change in the perception of wakefulness-fatigue (subscale WM) and restlessness (subscale RU) of the Multidimensional Well-Being Questionnaire (MDBF) between group I and group II with a comparison of baseline and end-of-study values.

Secondary

MeasureTime frame
Secondary endpoints: Follow-up comparison between groups I and III to assess the effectiveness of conditioning based on the change in the perception of wakefulness-fatigue and restlessness (subscale RU) of the Multidimensional Mood Questionnaire (MDBF).

Countries

Germany

Contacts

Public ContactMartin Bogdanski

Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie Charité Universitätsmedizin Berlin

martin.bogdanski@charite.de+4930450566288

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026